Country: USA

Canada
China
France
Germany
Italy
Japan
Netherlands
Spain

Investors

Safety Data Sheets
Package Inserts
Sign in

Investors

Country: USA

Canada
China
France
Germany
Italy
Japan
Netherlands
Spain

Products
Careers
About
Support
Women’s Health Index

Investors Menu

Home
Stock Information
Financials
Governance
Press Releases
Events & Presentations
Investor Resources
Sustainability

Site Search

Investor Relations

We are an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment.

Home
Stock Information
Financials
Governance
Press Releases
Events & Presentations
Investor Resources
Sustainability

Why Invest?

Learn More

Recent News

All Press Releases

All Quarters

Latest Event

Current Corporate Presentation

All Events

Quicklinks

opens in a new windowCorporate Presentation

opens in a new windowFast Facts

Investor Relations Contacts

Michael Watts

Vice President, Investor Relations and Corporate Communications

858.410.8588

michael.watts@hologic.com

Ryan Simon

Vice President, Investor Relations

858.410.8514

ryan.simon@hologic.com

Francis Pruell

Director, Investor Relations

508.263.8628

francis.pruell@hologic.com

Paula Izidoro

Senior Investor Relations Specialist

858.410.8904

paula.izidoro@hologic.com

Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Hologic, Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Hologic, Inc. to send you the requested Investor Email Alert updates.

* Required

Email Address *

Mailing Lists *

News Releases
Events
Presentations
SEC Filings
End of Day Stock Quote



Enter the code shown above.

Email Alert Sign Up Confirmation

Disclaimer

Please note that you are now entering a website directly or indirectly maintained by a third party (the "External Site") and that you do so at your own risk.

Hologic, Inc. ("Hologic") has no control over the External Site, any data or other content contained therein or any additional linked websites. The link to the External Site is provided for convenience purposes only.

By clicking "Accept" you acknowledge and agree that neither Hologic nor third party provider Virtua Research, Inc. ("Virtua") is responsible, or accepts or assumes any responsibility or liability whatsoever for, the content, the data or the technical operation of the Site. Further, by entering the External Site, you also acknowledge and agree that you completely and irrevocably waive any and all rights and claims against Hologic and Virtua and further acknowledge and agree that in no event shall Hologic or Virtua, or their respective officers, employees, directors and agents be liable for any (i) indirect, consequential, incidental, special, compensatory or punitive damages, (ii) damages for loss of income, loss of business profits, business interruption, loss of data or business information, loss of or damage to property, (iii) claims of third parties, or (iv) other pecuniary loss, arising out of or related to this disclaimer or the External Site.

By entering the External Site, you further acknowledge and agree that the disclaimer of warranties and limitations of liability set out in this disclaimer shall apply regardless of the causes, circumstances or form of action giving rise to the loss, damage, claim or liability, even if such loss, damage, claim or liability is based upon breach of contract (including, without limitation, a claim of fundamental breach or breach of a fundamental term), tort (including, without limitation, negligence), strict liability or any other legal or equitable theory, and even if Hologic and Virtua are advised of the possibility of the loss, damage, claim or liability. The waiver and release specifically includes, without limitation, any and all rights and claims pertaining to the processing of personal data, including but not limited to any rights under any applicable data protection statute(s).

If in any jurisdiction, any part of this disclaimer is held to be unenforceable by a court of competent jurisdiction, such part of this disclaimer shall be restricted or eliminated to the minimum extent and the remaining parts of the disclaimer shall otherwise remain in full force and effect.

Please note the information presented is deemed representative at the time of its original release. Changes in historical information may occur due to adjustments in accounting and reporting standards & procedures.

Non-GAAP Information

In addition to disclosing results determined in accordance with GAAP, Hologic may also disclose certain non-GAAP and pro forma non-GAAP results of operations, including certain ratios, operational and miscellaneous data, as well as net income, diluted earnings per share, operating expenses, and operating income that make certain adjustments or exclude certain charges and gains that are outlined in the schedules included in this website. Management believes that this non-GAAP and pro forma non-GAAP information provides investors with additional information to assess Hologic's operating performance by making certain adjustments or excluding costs or gains and assists investors in comparing Hologic's operating performance to prior periods. Management uses this non-GAAP and pro forma non-GAAP information, along with GAAP information, in evaluating its historical operating performance.

The non-GAAP information is not prepared in accordance with GAAP and may not be comparable to non-GAAP information used by other companies. The non-GAAP information should not be viewed as a substitute for, or superior to, other data prepared in accordance with GAAP.

Hologic and Virtua also take no responsibility for third party pricing data provided for informational purposes and certain ratio results formulated from the provided third party pricing data.

Decline Accept

Products
Careers
About
Support
Women's Health Index

Contact
Privacy Policy
Terms & Conditions
Patent Info